Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma

Virulence. 2024 Dec;15(1):2421231. doi: 10.1080/21505594.2024.2421231. Epub 2024 Nov 20.

Abstract

Hepatitis B virus (HBV) infection poses a challenge to global public health. Persistent liver infection with HBV is associated with an increased risk of developing severe liver disease. The complex interaction between the virus and the host is the reason for the persistent presence of HBV and the risk of tumor development. Chronic liver inflammation, integration of viral genome with host genome, expression of HBx protein, and viral genotype are all key participants in the pathogenesis of hepatocellular carcinoma (HCC). Epigenetic regulation in HBV-associated HCC involves complex interactions of molecular mechanisms that control gene expression and function without altering the underlying DNA sequence. These epigenetic modifications can significantly affect the onset and progression of HCC. This review summarizes recent research on the epigenetic regulation of HBV persistent infection and HBV-HCC development, including DNA methylation, histone modification, RNA modification, non-coding RNA, etc. Enhanced knowledge of these mechanisms will offer fresh perspectives and potential targets for intervention tactics in HBV-HCC.

Keywords: HBV; HCC; Hepatitis B virus; epigenetic modification; hepatocellular carcinoma.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / virology
  • DNA Methylation
  • Epigenesis, Genetic*
  • Hepatitis B virus* / genetics
  • Hepatitis B virus* / pathogenicity
  • Hepatitis B, Chronic* / complications
  • Hepatitis B, Chronic* / genetics
  • Hepatitis B, Chronic* / pathology
  • Hepatitis B, Chronic* / virology
  • Host-Pathogen Interactions / genetics
  • Humans
  • Liver Neoplasms* / genetics
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / virology

Grants and funding

The National Key Research and Development Program [2022YFC2603500, 2022YFC2603505]; Beijing Hospitals Authority Clinical medicine Development of special funding support [XMLX 202127]; The Digestive Medical Coordinated Development Center of Beijing Hospitals Authority [XXZ0302]; The capital health research and development of special public health project [2022-1-2172]; Beijing Municipal Health Commission high-level public health technical personnel construction project, discipline leader -03-26; Beijing Hospitals Authority Clinical medicine Development of special funding support [ZLRK202301].